Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03985488 · ClinicalTrials.gov registry record
Radiation Exposure Assessment in Fluoroscopy
A clinical trial, sponsored by AdventHealth.
- Completed
- Registry status
- 150
- Enrollment target
NCT03985488: Completed study, sponsored by AdventHealth.
NCT03985488 is a clinical trial that has completed, run by AdventHealth. The registered enrollment target is 150 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03985488 has completed, sponsored by AdventHealth.
- COMPLETED
- Registry status
- 150 participants
- Enrollment target
Study Summary
There has been increasing awareness regarding the risk of radiation exposure to patients and providers when performing procedures requiring fluoroscopic guidance.
Primary Outcome
Measurement of the degree of radiation exposure to patients and providers when performing endoscopic procedures with fluoroscopy guidance, with and without the FluroShield radiation exposure reduction system will be measured. The data will be collected in microgray per meter squared (Dap meter) and milligray (cumulative air KERMA).
Interventions
- RADIATION Radiation exposure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2019-05-06 |
| Est. Completion | 2020-01-31 |
What the finished NCT03985488 record still lists
NCT03985488 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Radiation exposure is the first listed.
NCT03985488 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03985488 about?
NCT03985488 is a clinical study titled "Radiation Exposure Assessment in Fluoroscopy". There has been increasing awareness regarding the risk of radiation exposure to patients and providers when performing procedures requiring fluoroscopic guidance.
What is the current status of trial NCT03985488?
This trial is currently completed. The enrollment target is 150 participants. The study started on 2019-05-06. Estimated completion is 2020-01-31.
What interventions are being tested in trial NCT03985488?
The interventions under investigation include: Radiation exposure (RADIATION).
Who is sponsoring clinical trial NCT03985488?
This trial is sponsored by AdventHealth, which has 95 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI